$2.9 Billion is the total value of EcoR1 Capital, LLC's 80 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | $314,513,000 | -25.8% | 11,584,280 | 0.0% | 10.86% | -18.1% | |
| APLS | APELLIS PHARMACEUTICALS INC | $234,395,000 | -11.0% | 5,183,431 | 0.0% | 8.09% | -1.8% | |
| ANAB | ANAPTYSBIO INC | $152,677,000 | -17.9% | 7,521,024 | 0.0% | 5.27% | -9.5% | |
| KURA | KURA ONCOLOGY INC | $121,681,000 | +14.0% | 6,638,371 | 0.0% | 4.20% | +25.8% | |
| MORF | MORPHIC HLDG INC | $85,749,000 | -46.0% | 3,951,566 | 0.0% | 2.96% | -40.4% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $84,420,000 | -41.8% | 5,991,479 | 0.0% | 2.91% | -35.8% | |
| RETA | REATA PHARMACEUTICALS INCcl a | $60,039,000 | -7.2% | 1,975,611 | 0.0% | 2.07% | +2.3% | |
| ARGX | ARGENX SEsponsored adr | $47,360,000 | +20.2% | 125,000 | 0.0% | 1.64% | +32.6% | |
| 2SEVENTY BIO INC | $46,146,000 | -22.6% | 3,495,943 | 0.0% | 1.59% | -14.6% | ||
| NUVB | NUVATION BIO INC | $45,025,000 | -38.4% | 13,896,543 | 0.0% | 1.55% | -32.1% | |
| AVIR | ATEA PHARMACEUTICALS INC | $45,019,000 | -1.7% | 6,340,639 | 0.0% | 1.55% | +8.5% | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $43,527,000 | -24.5% | 1,646,260 | 0.0% | 1.50% | -16.7% | |
| RNA | AVIDITY BIOSCIENCES INC | $40,096,000 | -21.3% | 2,759,505 | 0.0% | 1.38% | -13.2% | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $19,083,000 | +10.6% | 895,503 | 0.0% | 0.66% | +22.0% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $18,784,000 | -17.9% | 2,359,808 | 0.0% | 0.65% | -9.5% | |
| JANX | JANUX THERAPEUTICS INC | $17,354,000 | -14.9% | 1,421,319 | 0.0% | 0.60% | -6.1% | |
| VENTYX BIOSCIENCES INC | $15,899,000 | -9.9% | 1,300,000 | 0.0% | 0.55% | -0.5% | ||
| ORIC | ORIC PHARMACEUTICALS INC | $15,313,000 | -16.1% | 3,418,068 | 0.0% | 0.53% | -7.4% | |
| OVID | OVID THERAPEUTICS INC | $13,152,000 | -31.5% | 6,117,400 | 0.0% | 0.45% | -24.5% | |
| KDNY | CHINOOK THERAPEUTICS INC | $12,068,000 | +6.9% | 690,000 | 0.0% | 0.42% | +18.1% | |
| AKUS | AKOUOS INC | $9,267,000 | -1.3% | 1,975,984 | 0.0% | 0.32% | +8.8% | |
| HOOK | HOOKIPA PHARMA INC | $8,150,000 | -28.5% | 5,000,000 | 0.0% | 0.28% | -21.3% | |
| SURF | SURFACE ONCOLOGY INC | $7,631,000 | -44.2% | 4,653,000 | 0.0% | 0.26% | -38.6% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $6,937,000 | -15.9% | 541,108 | 0.0% | 0.24% | -7.4% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $5,800,000 | +0.4% | 587,615 | 0.0% | 0.20% | +10.5% | |
| JYAC | JIYA ACQUISITION CORP | $4,940,000 | +0.5% | 500,000 | 0.0% | 0.17% | +11.0% | |
| ALGS | ALIGOS THERAPEUTICS INC | $4,778,000 | -43.7% | 3,948,360 | 0.0% | 0.16% | -38.0% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,984,000 | +0.5% | 400,000 | 0.0% | 0.14% | +11.3% | |
| ERASCA INC | $3,779,000 | -35.2% | 678,441 | 0.0% | 0.13% | -29.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $3,121,000 | -38.4% | 963,333 | 0.0% | 0.11% | -32.1% | |
| KNTE | KINNATE BIOPHARMA INC | $2,207,000 | +12.0% | 175,000 | 0.0% | 0.08% | +22.6% | |
| FVAM | 5 01 ACQUISITION CORP | $1,980,000 | +0.5% | 200,000 | 0.0% | 0.07% | +9.7% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $1,980,000 | +0.6% | 200,000 | 0.0% | 0.07% | +9.7% | |
| BLSA | BCLS ACQUISITION CORP | $1,980,000 | +0.3% | 200,000 | 0.0% | 0.07% | +9.7% | |
| VERV | VERVE THERAPEUTICS INC | $1,507,000 | -33.0% | 98,593 | 0.0% | 0.05% | -25.7% | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $1,472,000 | +0.1% | 150,000 | 0.0% | 0.05% | +10.9% | |
| DYN | DYNE THERAPEUTICS INC | $1,477,000 | -28.8% | 215,000 | 0.0% | 0.05% | -21.5% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $1,256,000 | -8.4% | 1,046,700 | 0.0% | 0.04% | 0.0% | |
| KRON | KRONOS BIO INC | $1,189,000 | -49.7% | 326,780 | 0.0% | 0.04% | -44.6% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $993,000 | +0.8% | 100,000 | 0.0% | 0.03% | +9.7% | |
| FLACW | FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202 | $658,000 | +0.5% | 66,665 | 0.0% | 0.02% | +15.0% | |
| PARDES BIOSCIENCES INC | $614,000 | -56.0% | 200,000 | 0.0% | 0.02% | -52.3% | ||
| OMEG | OMEGA ALPHA SPACcl a | $493,000 | +0.4% | 50,000 | 0.0% | 0.02% | +13.3% | |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $363,000 | -51.4% | 100,000 | 0.0% | 0.01% | -43.5% | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $331,000 | +0.9% | 33,333 | 0.0% | 0.01% | +10.0% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $306,000 | -25.5% | 150,000 | 0.0% | 0.01% | -15.4% | |
| SURROZEN INC*w exp 08/01/203 | $200,000 | -0.5% | 66,665 | 0.0% | 0.01% | +16.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KURA ONCOLOGY ORD | 32 | Q3 2023 | 10.5% |
| XENCOR ORD | 25 | Q3 2023 | 12.6% |
| ASSEMBLY BIOSCIENCES ORD | 23 | Q3 2020 | 19.0% |
| FIBROGEN ORD | 22 | Q1 2020 | 12.4% |
| PROTHENA ORD | 20 | Q3 2023 | 28.0% |
| IRONWOOD PHARMA CL A ORD | 20 | Q1 2020 | 13.9% |
| GALAPAGOS NV SPON ADR | 19 | Q3 2023 | 12.0% |
| MORPHIC HOLDING ORD | 18 | Q3 2023 | 8.5% |
| ARCUS BIOSCIENCES ORD | 17 | Q1 2022 | 7.1% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 8.3% |
View EcoR1 Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Mersana Therapeutics, Inc. | July 27, 2023 | 19,364,688 | 16.9% |
| TScan Therapeutics, Inc. | June 05, 2023 | 5,000,000 | 11.7% |
| 2seventy bio, Inc. | February 14, 2023 | 1,143,494 | 3.0% |
| Avidity Biosciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Surface Oncology, Inc. | February 13, 2023 | 3,924,713 | 6.5% |
| Akouos, Inc.Sold out | February 10, 2023 | 0 | 0.0% |
| Alector, Inc. | February 10, 2023 | 4,056,548 | 4.9% |
| Arcus Biosciences, Inc.Sold out | February 10, 2023 | 0 | 0.0% |
| Gritstone bio, Inc.Sold out | February 10, 2023 | 0 | 0.0% |
| Ovid Therapeutics Inc. | February 10, 2023 | 6,117,400 | 8.7% |
View EcoR1 Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-03 |
| SC 13G/A | 2024-04-08 |
| 3 | 2024-03-26 |
| SC 13G/A | 2024-03-26 |
| SC 13G | 2024-03-11 |
| SC 13D | 2024-02-22 |
| SC 13G | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View EcoR1 Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.